Sharps Compliance (SMED) Misses Q3 EPS by 5c, Miss on Revenues

Sharps Compliance (NASDAQ: SMED) reported Q3 EPS of ($0.05), $0.05 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $9.4 million versus the consensus estimate of $9.72 million.

• Quarterly revenue of $9.4 million increased 10% over the prior year third quarter
• Unused Medication solutions business increased 111%; represents over 20% of total Company billings
• Route-based business increased 15%
• Unused medication management and route-based services represented over 40% of the Company’s March 2018 quarter customer billing
• MedSafe collection receptacles installed base of 2,173 units versus 876 a year ago
• Retail market billings increased 104%

For earnings history and earnings-related data on Sharps Compliance (SMED) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c